Classification of epilepsies and seizures: Historical perspective and future directions

Handbook of Clinical Neurology

Volumn 107, Issue , 2012, Pages 99-111

  Berg, Anne T ^a   Cross, J Helen ^b  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b YOUNG EPILEPSY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84865608893     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52898-8.00005-7     Document Type: Chapter

References (70)

1. Badawy R., Macdonell R., Jackson G., et al. The peri-ictal state: cortical excitability changes within 24h of a seizure. Brain 2009, 132:1013-1021.
2. Barkovich A.J., Kuzniecky R.I., Jackson G.D., et al. A developmental and genetic classification for malformations of cortical development. Neurology 2005, 65:1873-1887.
3. Berg A.T. The natural history of mesial temporal lobe epilepsy. Current Opin Neurol 2008, 21:173-178.
4. Berg A.T., Blackstone N.W. Of cabbages and kings: perspectives on classification from the field of systematics. Epilepsia 2003, 44:8-12.
5. Berg A.T., Blackstone N.W. Concepts in classification and their relevance to epilepsy. Epilepsy Res 2006, 70:11-19.
6. Berg A.T., Levy S.R., Testa F.M., et al. Classification of childhood epilepsy syndromes in newly diagnosed epilepsy: interrater agreement and reasons for disagreement. Epilepsia 1999, 40:439-444.
7. Berg A.T., Berkovic S.F., Brodie M.J., et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010, 51:676-685.
8. Berhardt B.C., Worsley K.J., Kim H., et al. Longitudinal and cross sectional analysis of atrophy in pharmacoresistant temporal lobe epilepsy. Neurology 2009, 72:1747-1754.
9. Blume W.T., Luders H.O., Mizrahi E., et al. Glossary of descriptive terminology for ictal semiology. International League Against Epilepsy. Epilepsia 2001, 42:1212-1218.
10. Callenbach P.M., Geerts A.T., Arts W.F., et al. Familial occurrence of epilepsy in children with newly diagnosed multiple seizures: Dutch Study of Epilepsy in Childhood. Epilepsia 1998, 39:331-336.
11. Capovilla G., Berg A.T., Cross J.H., et al. Conceptual dichotomies in classifying epilepsies: partial versus generalized and idiopathic versus symptomatic (April 18-20th, 2008, Monreale, Italy). Epilepsia 2009, (Epub ahead of print).
12. Chugani H.T., Asano E., Sood S. Infantile spasms: who are the ideal surgical candidates?. Epilepsia 2010, 51:94-96.
13. Claes L., Del-Favero J., Ceulemans B., et al. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 2001, 68:1327-1332.
14. Commission on Classification and Terminology of the International League Against Epilepsy Proposal for revised clinical and electrographic classification of epileptic seizures. Epilepsia 1981, 22:489-501.
15. Commission on Classification and Terminology of the International League Against Epilepsy Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989, 30:389-399.
16. Cross J.H., Jaykar P., Nordli D., et al. Proposed criteria for referral and evaluation of children for epilepsy surgery: recommendations of the Subcommission for Pediatric Epilepsy Surgery. Epilepsia 2006, 47:953-959.
17. Dibbens L.M., Tarpey P.S., Hynes K., et al. X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment. Nat Genet 2008, 40:776-781.
18. Dulac O. Epileptic encephalopathy. Epilepsia 2001, 42:23-26.
19. Engel J. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001, 42:796-803.
20. Engel J. Report of the ILAE Classification Core Group. Epilepsia 2006, 47:1558-1568.
21. Feero W.G., Guttmacher A.E., Collins F.S. Genomic medicine - an updated primer. N Engl J Med 2010, 362:2001-2011.
22. Fisher R.S., Boas W.V.E., Blume W., et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005, 46:470-472.
23. Gaillard W.D., Chiron C., Cross J.H., et al. Guidelines for imaging infants and children with recent-onset epilepsy. Epilepsia 2009, 50:2147-2153.
24. Gastaut H. Clinical and electroencephalographical classification of epileptic seizures. Epilepsia 1969, 10:S2-S13.
25. Gastaut H. Classification of the epilepsies. Proposal for an international classification. Epilepsia 1969, 10:S14-S21.
26. Harkin L.A., McMahon J.M., Iona X., et al. The spectrum of SCN1A-related infantile epileptic encephalopathies. Brain 2007, 130:843-852.
27. Hayden E.C. Life is complicated. Nature 2010, 464:664-669.
28. Hermann B.P., Seidenberg M., Dow C., et al. Cognitive prognosis in chronic temporal lobe epilepsy. Ann Neurol 2006, 60:80-87.
29. Hirtz D., Ashwal S., Berg A.T., et al. Evaluating a first nonfebrile seizure in children: an evidence-based practice parameter. Neurology 2000, 55:616-623.
30. Hoda J.-C., Gu W., Friedli M., et al. Human nocturnal frontal lobe epilepsy: pharmacogenomic profiles of pathogenic nicotinic acetylcholine receptor B-subunit mutations outside the ion channel pore. Mol Pharmacol 2008, 74:379-391.
31. Jackson G.D., Calamante F., Tournier J.-D., et al. New anatomic MRI techniques. Epilepsia 2010, 51:80-82.
32. Jallon P., Loiseau P., Loiseau J. Newly diagnosed unprovoked epileptic seizures: presentation at diagnosis in CAROLE study. Epilepsia 2001, 42:464-475.
33. Jonas R., Asarnow R.F., LoPresti C., et al. Surgery for symptomatic infant-onset epileptic encephalopathy with and without infantile spasms. Neurology 2005, 64:746-750.
34. Kanner A.M. Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment. Biol Psychiatry 2003, 54:388-398.
35. Kanner A.M. Depression in epilepsy: a complex relation with unexpected consequences. Curr Opin Neurol 2008, 21:190-194.
36. Kimiskidis V.K. Transcranial magnetic stimulation for drug-resistant epilepsies: rational and clinical experience. Eur Neurol 2009, 63:205-210.
37. Klepper J., Leiendecker B. GLUT1 deficiency syndrome - 2007 update. Dev Med Child Neurol 2007, 49:707-716.
38. Koster J.C., Cadario F., Peruzzi C., et al. The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy. J Clin Endocrinol Metab 2008, 93:1054-1061.
39. Koster J.C., Kurtara H.T., Enkvetchakul D., et al. DEND mutation in Kir6.2 (KCNJ11) reveals a flexible N-terminal region critical for ATP-sensing of the KATP channel. Biophys J 2008, 95:4689-4697.
40. Kwan P., Arzimanoglou A., Berg A.T., et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010, 51:1069-1077.
41. Lee Y.J., Kang H.-C., Lee J.S., et al. Resective pediatric epilepsy surgery in Lennox-Gastaut syndrome. Pediatrics 2010, 125:e58-e66.
42. Leen W.G., Klepper J., Verbeek M.M., et al. Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain 2010, 133:655-670.
43. Lerner J.T., Salamon N., Hauptman J.S., et al. Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: a critical review and the UCLA experience. Epilepsia 2009, 50:1310-1335.
44. Lin H., Holmes G.L., Kubie J.L., et al. Recurrent seizures induce a reversible impairment in a spatial hidden goal task. Hippocampus 2009, 19:817-827.
45. Madan N., Grant P.E. New directions in clinical imaging of cortical dysplasias. Epilepsia 2009, 50:9-18.
46. Merlis J.K. Proposal for an international classification of the epilepsies. Epilepsia 1970, 11:114-119.
47. National Association of Epilepsy Centers Guidelines for essential services, personnel, and facilities in specialized epilepsy centers in the United States. Epilepsia 2001, 42:804-814.
48. National Institute for Clinical Excellence The Epilepsies: Diagnosis and Management of the Epilepsies in Children and Young People in Primary and Secondary Care. Clinical Guideline 2004, 20. NICE, London.
49. Panayiotopoulos C.P. The birth and evolution of the concept of Panayiotopoulos syndrome. Epilepsia 2007, 48:1041-1043.
50. Panayiotopoulos C.P. Typical absence seizures and related epileptic syndromes: assessment of current state and directions for future research. Epilepsia 2008, 49:2131-2139.
51. Roulet-Perez E., Ballhausen D., Bonafé L., et al. Glut-1 deficiency syndrome masquerading as idiopathic generalized epilepsy. Epilepsia 2008, 49:1955-1958.
52. Saitsu H., Kato M., Mizuguchi T., et al. De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy. Nat Genet 2008, 40:782-788.
53. Sakurai K., Takeda Y., Tanaka N., et al. Generalized spike-wave discharges involve a default mode network in patients with juvenile absence epilepsy: a MEG study. Epilepsy Res 2010, 89:176-184.
54. Scheffer I.E., Turner S.J., Dibbens L.M., et al. Epilepsy and mental retardation limited to females: an under-recognized disorder. Brain 2008, 131:918-927.
55. Spencer S.S. Neural networks in human epilepsy: evidence of and implications for treatment. Epilepsia 2002, 43:219-227.
56. Stefan H., Paulini-Ruf A., Hopfengärtner R., et al. Network characteristics of idiopathic generalized epilepsies in combined MEG/EEG. Epilepsy Res 2009, 85:187-198.
57. Steinlein O.K., Mulley J.C., Propping P., et al. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 1995, 11:201-203.
58. Steinlein O.K., Magnusson A., Stoodt J., et al. An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Hum Mol Genet 1997, 6:943-947.
59. Sugawara T., Mazaki-Miyazaki E., Fukushima K., et al. Frequent mutations of SCN1A in severe myoclonic epilepsy in infancy. Neurology 2002, 58:1122-1124.
60. Suls A., Dedeken P., Goffin K., et al. Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain 2008, 131:1831-1844.
61. Suls A., Mullen S.A., Weber Y.G., et al. Early-onset absence epilepsy caused by mutations in the glucose transporter GLUT1. Ann Neurol 2009, 66:415-419.
62. Talos D.M., Kwiatkowski D.J., Cordero K., et al. Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers. Ann Neurol 2008, 63:454-465.
63. Vahedi K., Depienne C., Le Fort D., et al. Elicited repetitive daily blindness: a new phenotype associated with hemiplegic migraine and SCN1A mutations. Neurology 2009, 72:1178-1183.
64. van Luijtelaar G., Sitnikova E. Global and focal aspects of absence epilepsy: the contribution of genetic models. Neurosci Biobehav Rev 2006, 30:983-1003.
65. Venter J.C., Adams M.D., Myers E.W., et al. The sequence of the human genome. Science 2001, 291:1304-1351.
66. Vulliemoz S., Lemieux L., Daunizeau J., et al. The combination of EEG source imaging and EEG-correlated functional MRI to map epileptic networks. Epilepsia 2010, 51:491-505.
67. Wheless J.W., Clarke D.F., Carpenter D. Treatment of pediatric epilepsy: expert opinion, 2005. J Child Neurol 2005, 20:S1-S56.
68. Wheless J.W., Clarke D.F., Arzimanoglou A., et al. Treatment of pediatric epilepsy: European expert opinion, 2007. Epileptic Disord 2007, 9:353-412.
69. Wong M. Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies. Epilepsia 2010, 51:27-36.
70. York G.K., Steinberg D.A. Hughlings Jackson's suggestion for the treatment of epilepsy. Neurology 2009, 73:1155-1158.